We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Presidio Pharmaceuticals and Numerate Announce Research Collaboration to Identify Improved Hepatitis C Therapeutics

The research collaboration is focused to discover and develop novel small molecule inhibitors of hepatitis C virus (HCV).
News

Unidym Ramps up Manufacturing to Meet Carbon Nanotube Demand

Company to expand its manufacturing operations to meet the demand for carbon nanotubes used by both its transparent electrode business and the market in general.
News

Spectrum Pharmaceuticals Initiates Phase 1 Study of a Novel Adjunct to Cancer Chemotherapy

The Phase 1 trial is an open label, dose-escalation study assessing the pharmacokinetics and pharmacodynamics of SPI-1620 in patients with recurrent or progressive carcinoma.
News

454 Life Sciences Launches new Products and Software for Genome Sequencer FLX System

The Company says that the new additions expand researchers’ ability to customize their sequencing projects to achieve scientifically meaningful results.
News

Formulatrix Formulator™ Wins ALA new Product Award

The Formulator is a next-generation liquid handler that uses patent-pending microfluidic technology to dispense liquids into microplates.
News

GSK Extends GeneGo License and Adds new Products

This will provide GSK researchers in Bioinformatics, R&D and clinical studies with global access to MetaCore, MapEditor and MetaBase.
News

Chemical Signature of Manic Depression Discovered by Scientists

People with manic depression have a distinct chemical signature in their brains, according to a new study.
News

Online Resource for Peptide Chemists

Activotec has announced the launch of an updated information-rich website.
News

Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests

Vermillion obtains exclusive rights the development of biomarkers that can be applied toward disease detection, classification and monitoring of prevalent cancers.
News

DiscoveRx Corporation Signs Agreement with Cosmo Bio

DiscoveRx Corporation announces the selection of Cosmo Bio as a key distributor for the Japanese territory.
Advertisement